Taking on The Thames Path Challenge
Next month, Anisha and Sheena will take on The Thames Path Challenge. Together, they explain why they decided to join #TeamRetinaUK.
Search results
Next month, Anisha and Sheena will take on The Thames Path Challenge. Together, they explain why they decided to join #TeamRetinaUK.
Whether you're an expert runner, or a rebel *with* a cause, there's no better experience than the London Marathon!
Have you ever been tempted to take part in the TCS London Marathon? In 2022 the TCS London Marathon raised £58.3 million for charity so it’s a vital source of income.
Mirugen – Unlocking the Power of Retina Regeneration
Introducing Splice Bio, a genetic medicines company with some exciting developments for Stargardt’s patients.
Opus Genetics has launched an early-stage clinical trial of OPGx-MERTK, an investigational gene therapy for MERTK-related Retinitis Pigmentosa (RP), a condition that causes progressive vision loss due to photoreceptor degeneration.
Retina UK has invested more than £16million into cutting-edge research since the charity was founded in 1976.
Researchers in the Netherlands are developing a “retina-on-a-chip” that mimics the key layers of the human retina, offering a powerful new way to study inherited retinal diseases (IRDs) and test potential treatments using human cells.
Autoimmune diseases are quite distinct from inherited retinal dystrophies.
This page explains the different types of genetic tests: diagnostic testing, predictive testing, carrier testing and research testing